BERKELEY, Calif.--(BUSINESS WIRE)--Plexxikon Inc. today announced Gary C. Visor, Ph.D. was named vice president, pharmaceutics, a new position responsible for managing pharmaceutical drug substance scale-up, manufacturing and dosage design and development, required for the company’s development programs. In addition, David H. MacCallum has been appointed to Plexxikon’s board of directors.
